Phase II Trial of Bevacizumab Combined With Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bevacizumab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 13 Aug 2021 Biomarkers information updated
- 15 Jun 2006 New trial record.